[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Biologic Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

December 2018 | 136 pages | ID: GFDF0910C30EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.

Scope of the Report:

This report studies the Biologic Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biologic Therapeutics market by product type and applications/end industries.
First and foremost, increasing reimbursement for biologics is predicted to positively influence the biologic therapeutics market in the upcoming years. Medical insurance companies and state-run insurance schemes are increasingly accepting claims against biologic therapeutics. Biologic therapeutics are gaining popularity due the efficacy of biologic therapeutic drugs and fewer side effects than chemical-based drugs. This is because biologic drugs are obtained from natural sources such as plants, or even living components such as cells and tissues of animals, microorganisms, or humans. These fragments are further treated to make therapeutic products such as blood components, vaccines, and recombinant therapeutic proteins.
Increasing prevalence of chronic diseases such as cancer, diabetes, and coronary artery diseases and a growing geriatric population are some other factors contributing to the biologic therapeutics market. In addition, mounting clinical trials and innovative research and development practices to develop novel drugs is boosting the growth of biologic therapeutics market.
On the flip side, manufacturing difficulties due to complexities of drug molecules is challenging the growth of biologic therapeutics market. Nevertheless, increasing research and development in the pharmaceutical sector and rising applications of biologics is anticipated to provide new opportunities to this market.
The global Biologic Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biologic Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
  • Pfizer
  • Novartis Global
  • AstraZeneca
  • Merck
  • GlaxoSmithKline
  • Aurobindo Pharma
Market Segment by Regions, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
  • Vaccines
  • Blood Products
  • Allergenic Extracts
  • Human Cells and Tissues
  • Gene Therapies
  • Protein
  • Cellular Therapies
  • Xenotransplantation Products
Market Segment by Applications, can be divided into
  • Rheumatoid Arthritis
  • Anemia
  • Cancer
  • Diabetes
  • Others
1 BIOLOGIC THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Biologic Therapeutics
1.2 Classification of Biologic Therapeutics by Types
  1.2.1 Global Biologic Therapeutics Revenue Comparison by Types (2017-2023)
  1.2.2 Global Biologic Therapeutics Revenue Market Share by Types in 2017
  1.2.3 Vaccines
  1.2.4 Blood Products
  1.2.5 Allergenic Extracts
  1.2.6 Human Cells and Tissues
  1.2.7 Gene Therapies
  1.2.8 Protein
  1.2.9 Cellular Therapies
  1.2.10 Xenotransplantation Products
1.3 Global Biologic Therapeutics Market by Application
  1.3.1 Global Biologic Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Rheumatoid Arthritis
  1.3.3 Anemia
  1.3.4 Cancer
  1.3.5 Diabetes
  1.3.6 Others
1.4 Global Biologic Therapeutics Market by Regions
  1.4.1 Global Biologic Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Biologic Therapeutics Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Biologic Therapeutics Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biologic Therapeutics Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Biologic Therapeutics Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biologic Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Biologic Therapeutics (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Pfizer
  2.1.1 Business Overview
  2.1.2 Biologic Therapeutics Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Pfizer Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis Global
  2.2.1 Business Overview
  2.2.2 Biologic Therapeutics Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Novartis Global Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 AstraZeneca
  2.3.1 Business Overview
  2.3.2 Biologic Therapeutics Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 AstraZeneca Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
  2.4.1 Business Overview
  2.4.2 Biologic Therapeutics Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Merck Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline
  2.5.1 Business Overview
  2.5.2 Biologic Therapeutics Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 GlaxoSmithKline Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Aurobindo Pharma
  2.6.1 Business Overview
  2.6.2 Biologic Therapeutics Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Aurobindo Pharma Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL BIOLOGIC THERAPEUTICS MARKET COMPETITION, BY PLAYERS

3.1 Global Biologic Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Biologic Therapeutics Players Market Share
  3.2.2 Top 10 Biologic Therapeutics Players Market Share
3.3 Market Competition Trend

4 GLOBAL BIOLOGIC THERAPEUTICS MARKET SIZE BY REGIONS

4.1 Global Biologic Therapeutics Revenue and Market Share by Regions
4.2 North America Biologic Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Biologic Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biologic Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Biologic Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biologic Therapeutics Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA BIOLOGIC THERAPEUTICS REVENUE BY COUNTRIES

5.1 North America Biologic Therapeutics Revenue by Countries (2013-2018)
5.2 USA Biologic Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Biologic Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Biologic Therapeutics Revenue and Growth Rate (2013-2018)

6 EUROPE BIOLOGIC THERAPEUTICS REVENUE BY COUNTRIES

6.1 Europe Biologic Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Biologic Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Biologic Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Biologic Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Biologic Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Biologic Therapeutics Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC BIOLOGIC THERAPEUTICS REVENUE BY COUNTRIES

7.1 Asia-Pacific Biologic Therapeutics Revenue by Countries (2013-2018)
7.2 China Biologic Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Biologic Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Biologic Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Biologic Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Biologic Therapeutics Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA BIOLOGIC THERAPEUTICS REVENUE BY COUNTRIES

8.1 South America Biologic Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Biologic Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Biologic Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Biologic Therapeutics Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE BIOLOGIC THERAPEUTICS BY COUNTRIES

9.1 Middle East and Africa Biologic Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Biologic Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Biologic Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Biologic Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Biologic Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Biologic Therapeutics Revenue and Growth Rate (2013-2018)

10 GLOBAL BIOLOGIC THERAPEUTICS MARKET SEGMENT BY TYPE

10.1 Global Biologic Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Biologic Therapeutics Market Forecast by Type (2018-2023)
10.3 Vaccines Revenue Growth Rate (2013-2023)
10.4 Blood Products Revenue Growth Rate (2013-2023)
10.5 Allergenic Extracts Revenue Growth Rate (2013-2023)
10.6 Human Cells and Tissues Revenue Growth Rate (2013-2023)
10.7 Gene Therapies Revenue Growth Rate (2013-2023)
10.8 Protein Revenue Growth Rate (2013-2023)
10.9 Cellular Therapies Revenue Growth Rate (2013-2023)
10.10 Xenotransplantation Products Revenue Growth Rate (2013-2023)

11 GLOBAL BIOLOGIC THERAPEUTICS MARKET SEGMENT BY APPLICATION

11.1 Global Biologic Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Biologic Therapeutics Market Forecast by Application (2018-2023)
11.3 Rheumatoid Arthritis Revenue Growth (2013-2018)
11.4 Anemia Revenue Growth (2013-2018)
11.5 Cancer Revenue Growth (2013-2018)
11.6 Diabetes Revenue Growth (2013-2018)
11.7 Others Revenue Growth (2013-2018)

12 GLOBAL BIOLOGIC THERAPEUTICS MARKET SIZE FORECAST (2018-2023)

12.1 Global Biologic Therapeutics Market Size Forecast (2018-2023)
12.2 Global Biologic Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Biologic Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Biologic Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Biologic Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Biologic Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Biologic Therapeutics Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES

Figure Biologic Therapeutics Picture
Table Product Specifications of Biologic Therapeutics
Table Global Biologic Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Biologic Therapeutics Revenue Market Share by Types in 2017
Figure Vaccines Picture
Figure Blood Products Picture
Figure Allergenic Extracts Picture
Figure Human Cells and Tissues Picture
Figure Gene Therapies Picture
Figure Protein Picture
Figure Cellular Therapies Picture
Figure Xenotransplantation Products Picture
Table Global Biologic Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure Biologic Therapeutics Revenue Market Share by Applications in 2017
Figure Rheumatoid Arthritis Picture
Figure Anemia Picture
Figure Cancer Picture
Figure Diabetes Picture
Figure Others Picture
Table Global Market Biologic Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Biologic Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Biologic Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Biologic Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Biologic Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Biologic Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Biologic Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Biologic Therapeutics Type and Applications
Table Pfizer Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Global Basic Information, Manufacturing Base and Competitors
Table Novartis Global Biologic Therapeutics Type and Applications
Table Novartis Global Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Biologic Therapeutics Type and Applications
Table AstraZeneca Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Biologic Therapeutics Type and Applications
Table Merck Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Biologic Therapeutics Type and Applications
Table GlaxoSmithKline Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table Aurobindo Pharma Biologic Therapeutics Type and Applications
Table Aurobindo Pharma Biologic Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Biologic Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global Biologic Therapeutics Revenue Share by Players (2013-2018)
Figure Global Biologic Therapeutics Revenue Share by Players in 2016
Figure Global Biologic Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players Biologic Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players Biologic Therapeutics Revenue Market Share in 2017
Figure Global Biologic Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Biologic Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global Biologic Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Biologic Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Biologic Therapeutics Revenue Market Share by Regions in 2017
Figure North America Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Biologic Therapeutics Revenue by Countries (2013-2018)
Table North America Biologic Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Biologic Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Biologic Therapeutics Revenue Market Share by Countries in 2017
Figure USA Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Biologic Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Biologic Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe Biologic Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Biologic Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Biologic Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Biologic Therapeutics Revenue Market Share by Countries in 2017
Figure China Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure India Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Biologic Therapeutics Revenue by Countries (2013-2018)
Table South America Biologic Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Biologic Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Biologic Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Biologic Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Biologic Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Biologic Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Biologic Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa Biologic Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Biologic Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Biologic Therapeutics Revenue Share by Type (2013-2018)
Figure Global Biologic Therapeutics Revenue Share by Type (2013-2018)
Figure Global Biologic Therapeutics Revenue Share by Type in 2017
Table Global Biologic Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global Biologic Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global Vaccines Revenue Growth Rate (2013-2018)
Figure Global Blood Products Revenue Growth Rate (2013-2018)
Figure Global Allergenic Extracts Revenue Growth Rate (2013-2018)
Figure Global Human Cells and Tissues Revenue Growth Rate (2013-2018)
Figure Global Gene Therapies Revenue Growth Rate (2013-2018)
Figure Global Protein Revenue Growth Rate (2013-2018)
Figure Global Cellular Therapies Revenue Growth Rate (2013-2018)
Figure Global Xenotransplantation Products Revenue Growth Rate (2013-2018)
Table Global Biologic Therapeutics Revenue by Application (2013-2018)
Table Global Biologic Therapeutics Revenue Share by Application (2013-2018)
Figure Global Biologic Therapeutics Revenue Share by Application (2013-2018)
Figure Global Biologic Therapeutics Revenue Share by Application in 2017
Table Global Biologic Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global Biologic Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global Rheumatoid Arthritis Revenue Growth Rate (2013-2018)
Figure Global Anemia Revenue Growth Rate (2013-2018)
Figure Global Cancer Revenue Growth Rate (2013-2018)
Figure Global Diabetes Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Biologic Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Biologic Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Biologic Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Biologic Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe Biologic Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Biologic Therapeutics Revenue Market Forecast (2018-2023)
Figure South America Biologic Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Biologic Therapeutics Revenue Market Forecast (2018-2023)


More Publications